ImmuCell Corp. (ICCC)
6.30
-0.05
(-0.79%)
USD |
NASDAQ |
Apr 02, 16:00
6.30
0.00 (0.00%)
After-Hours: 17:55
ImmuCell Market Cap : 57.17M for April 2, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Cumberland Pharmaceuticals, Inc. | 44.37M |
| ACADIA Pharmaceuticals, Inc. | 3.794B |
| Alnylam Pharmaceuticals, Inc. | 41.99B |
| Savara, Inc. | 1.162B |
| BioMarin Pharmaceutical, Inc. | 10.82B |
Market Cap Related Metrics
| PS Ratio | 2.063 |
| Price to Book Value | 2.113 |
| Price to Free Cash Flow | 46.57 |
| Price | 6.30 |
| Earnings Yield | -1.80% |
| Operating PE Ratio | 34.59 |
| Normalized PE Ratio | 68.18 |